Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Journal of Neurology
|
December 24, 2025
CSF biomarkers of neuroinflammation are associated with regional atrophy
Serap Özlü, Martin Dyrba, Alice Grazia, et al.
The Lancet. Neurology
|
November 22, 2024
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
Yihua Ma, Carly M Farris, Sandrina Weber, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 22, 2024
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study
Christoph Linnemann, Carlo Wilke, David Mengel, et al.
Molecular Psychiatry
|
April 17, 2025
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease
David Mengel, Ester Soter, Julia Maren Ott, et al.
Neurology
|
January 27, 2026
Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive Aphasia
Lena Marth, Francisco J Martinez-Murcia, Juan-Manuel Górriz-Sáez, et al.
Alzheimer'S Research & Therapy
|
January 11, 2023
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study
Frederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Molecular Psychiatry
|
January 12, 2024
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition
Dayana Hayek, Gabriel Ziegler, Luca Kleineidam, et al.
Neuron
|
January 7, 2022
Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease
Frederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Nature Medicine
|
June 18, 2024
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Madhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.
Alzheimer'S Research & Therapy
|
March 28, 2024
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors
Imogen J Swift, Rosa Rademakers, NiCole Finch, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Journal of Neurology
|
December 24, 2025
CSF biomarkers of neuroinflammation are associated with regional atrophy
Serap Özlü, Martin Dyrba, Alice Grazia, et al.
The Lancet. Neurology
|
November 22, 2024
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
Yihua Ma, Carly M Farris, Sandrina Weber, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 22, 2024
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study
Christoph Linnemann, Carlo Wilke, David Mengel, et al.
Molecular Psychiatry
|
April 17, 2025
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease
David Mengel, Ester Soter, Julia Maren Ott, et al.
Neurology
|
January 27, 2026
Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive Aphasia
Lena Marth, Francisco J Martinez-Murcia, Juan-Manuel Górriz-Sáez, et al.
Alzheimer'S Research & Therapy
|
January 11, 2023
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study
Frederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Molecular Psychiatry
|
January 12, 2024
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition
Dayana Hayek, Gabriel Ziegler, Luca Kleineidam, et al.
Neuron
|
January 7, 2022
Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease
Frederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Nature Medicine
|
June 18, 2024
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Madhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.
Alzheimer'S Research & Therapy
|
March 28, 2024
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors
Imogen J Swift, Rosa Rademakers, NiCole Finch, et al.
Page
of 6